Francesco Saverio Mennini

基本信息

浏览量：114

职业迁徙

个人简介

His main contributions have dealt with Health Technology Assessment (HTA) and Pharmacoeconomics, Welfare policies, health system analysis, and pharmaceutical economics.
Prof. Mennini is member of Regional Scientific Commettee on HIV and HCV (from 2011).
Prof. Mennini is author of numerous publications, national and international, of Health
Economics, HTA and Economic Evaluation.

研究兴趣

论文共 189 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Analisi Di Costo-Efficacia Di Brentuximab Vedotin in Combinazione Con Doxorubicina, Vinblastina E Dacarbazina (AVD) in Pazienti Adulti Affetti Da Linfoma Di Hodgkin in Stadio IV

Andrea Marcellusi,Chiara Bini,Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Lina Molinari,Paolo Morelli, Stanimira Krotneva, Shujun Li

Global & regional health technology assessment (2024): 248-257

引用0浏览0WOS引用

Use of Inpatient Systemic Chemotherapy And/or Radiotherapy and Related Predictive Factors, Healthcare Resource Utilization, and Direct Hospitalization Costs for Metastatic Urothelial Cancer: Findings from a Real-World Retrospective Observational Study Derived from the National Hospital Discharge Claims Database in Italy

Mairead Kearney,Melissa Kirker, Allison Thompson, Norbek Gharibian, Martina Furegato, Cécile Pacheco, Seham Issa, Reyhan Hasanova,Paolo Sciattella, Matteo Scortichini,Francesco Saverio Mennini

BMC Cancerno. 1 (2024): 1-20

引用0浏览0WOS引用

Screening Strategy to Advance HCV Elimination in Italy: a Cost-Consequence Analysis

Andrea Marcellusi,Francesco Saverio Mennini,Massimo Andreoni,Loreta A. Kondili

EUROPEAN JOURNAL OF HEALTH ECONOMICS（2024）

引用0浏览0WOS引用

Comparing the Effectiveness and Cost-Effectiveness of Sulfonylureas and Newer Diabetes Drugs As Second-Line Therapy for Patients with Type 2 Diabetes

Matteo Franchi,Giacomo Pellegrini,Angelo Avogaro,Giuliano Buzzetti,Riccardo Candido,Arturo Cavaliere,Agostino Consoli, Irene Marzona,Francesco Saverio Mennini,Stefano Palcic,Giovanni Corrao

BMJ OPEN DIABETES RESEARCH & CAREno. 3 (2024)

引用0浏览0WOS引用

An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy

Francesco Saverio Mennini,Paolo Sciattella,Andrea Marcellusi, Fausto Bartolini,Francesca Futura Bernardi,Fleur Levrat-Guillen,Marianna Cozzolino,Massimo Di Gennaro,Roberta Giordana, Marianna Giustozzi,Ugo Trama

DIABETES THERAPY（2024）

引用0浏览0WOS引用

Enhancing Knowledge Brokerage Drivers for Dynamic Capabilities: the Effects on Sustainable Supply Chain Ecosystem

Monica Fait,Rosa Palladino,Francesco Saverio Mennini,Domenico Graziano,Martina Manzo

JOURNAL OF KNOWLEDGE MANAGEMENTno. 2 (2024): 355-380

引用1浏览0EI引用

The Economic Burden of Asthma in Italy: Evaluating the Potential Impact of Different Treatments in Adult Patients with Severe Eosinophilic Asthma

Matteo Scortichini,Francesco Saverio Mennini, Andrea Marcellusi,Martina Paoletti,Carlo Tomino,Paolo Sciattella

The European Journal of Health Economicspp.1-8, (2024)

引用0浏览0WOS引用

Cost-effectiveness of Brentuximab Vedotin Plus Chemotherapy As Frontline Treatment of Stage IV Hodgkin Lymphoma in Italy

Chiara Bini, Andrea Marcellusi,Francesco Saverio Mennini, Silvia Ripoli, Laura Fioravanti, Victoria Federico Paly, Alexa Molinari,Paolo Morelli, Stanimira Krotneva, Shujun Li

Global & Regional Health Technology Assessmentno. 1 (2024)

引用0浏览0引用

Health and Economic Outcomes of Pembrolizumab in the Treatment of Metastatic Non-small Cell Lung Cancer (mnsclc) and Melanoma in Italy

Martina Paoletti,Chiara Bini,Andrea Marcellusi,Francesco Saverio Mennini

Clinical Drug Investigationpp.1-9, (2024)

引用0浏览0WOS引用

Determinants of the Financial Impact of Orphan Drugs in Italy: Differences Between Expected and Observed Pharmaceutical Expenditure